Literature DB >> 16697897

Clinically useful vanilloid receptor TRPV1 antagonists: just around the corner (or too early to tell)?

Giovanni Appendino1, Arpad Szallasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16697897     DOI： 10.1016/S0079-6468(05)44404-5

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  3 in total

Review 1.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

2.  Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.

Authors:  Kumar Changani; Sarah Hotee; Simon Campbell; Kashmira Pindoria; Laura Dinnewell; Paula Saklatvala; Sally-Anne Thompson; Diane Coe; Keith Biggadike; Giovanni Vitulli; Marion Lines; Albert Busza; Jane Denyer
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 3.  Advances in TRP channel drug discovery: from target validation to clinical studies.

Authors:  Ari-Pekka Koivisto; Maria G Belvisi; Rachelle Gaudet; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2021-09-15       Impact factor: 112.288
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.